MarkNtel Advisors recently published a detailed industry analysis of the Global Spinal Muscular Atrophy (SMA) Treatment Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.

Global Spinal Muscular Atrophy (SMA) Treatment Market, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030

The Spinal Muscular Atrophy (SMA) Treatment Market size was valued at around USD 2.3 billion in 2023 and is projected to reach around USD 30.2 billion by 2030. Along with this, the market is anticipated to grow at a CAGR of around 18.2% during the forecast period, i.e., 2025-30.

What are the major Driver the Global Spinal Muscular Atrophy (SMA) Treatment industry?

Growing Incidence of the Disorder to Augment the Market – In terms of cost and healthcare services, the overall burden of spinal muscular atrophy is one of the highest in the rare disorder. With multiple incidences of spinal muscular atrophy popping up due to the increase in population, the requirement for SMA treatment is growing drastically on a global level. As per the Spinal Muscular Atrophy Foundation estimations, 1 in every 6000 to 10000 babies are diagnosed with this, despite being considered a rare disorder. Thus the rising rampancy of this disorder is one of the major factors that increases revenue generation from the market. Moreover, the rising awareness regarding novel therapies and the increasing number of product launches are some of the major factors deriving market growth. The high need for quality treatment options coupled with the awareness about the lethal backlash of the disorder will significantly aid in the development of the market.

Access the detailed PDF Sample report – https://www.marknteladvisors.com/query/request-sample/spinal-muscular-atrophy-sma-treatment-market.html

What segments define the Global Spinal Muscular Atrophy (SMA) Treatment Market from 2025 to 2030? How do these segments contribute to market dynamics and growth?

By Type

Type I- Market Size & Forecast 2020-2030, USD Million

Type II- Market Size & Forecast 2020-2030, USD Million

Type III- Market Size & Forecast 2020-2030, USD Million

Type IV- Market Size & Forecast 2020-2030, USD Million

According to report, SMA Type I has the largest number of SMA patients accounting for about 60% of them worldwide, according to the National Organization for Rare Disorders.

By Treatment

Gene Therapy- Market Size & Forecast 2020-2030, USD Million

Disease-Modifying Drugs- Market Size & Forecast 2020-2030, USD Million

According to report, In the Global Spinal Muscular Atrophy (SMA) Treatment Market gene therapy segment holds a market share of over 70%.

By Drug Type

Nusinersen- Market Size & Forecast 2020-2030, USD Million

Onasemnogene Abeparvovec- Market Size & Forecast 2020-2030, USD Million

Others- Market Size & Forecast 2020-2030, USD Million

By Route of Administration

Oral- Market Size & Forecast 2020-2030, USD Million

Injectable- Market Size & Forecast 2020-2030, USD Million

By Distribution Channel

Hospital Pharmacies- Market Size & Forecast 2020-2030, USD Million

Retail Pharmacies- Market Size & Forecast 2020-2030, USD Million

Online Pharmacies- Market Size & Forecast 2020-2030, USD Million

By End User

Hospitals- Market Size & Forecast 2020-2030, USD Million

Homecare- Market Size & Forecast 2020-2030, USD Million

Specialty Clinics- Market Size & Forecast 2020-2030, USD Million

Others- Market Size & Forecast 2020-2030, USD Million

Explore the Complete Global Spinal Muscular Atrophy (SMA) Treatment Market Analysis Report – https://www.marknteladvisors.com/research-library/spinal-muscular-atrophy-sma-treatment-market.html

Geographical Analysis: Global Spinal Muscular Atrophy (SMA) Treatment Market

By Region

North America

South America

Europe

The Middle East & Africa

Asia-Pacific

Global Spinal Muscular Atrophy (SMA) Treatment Market Share & Competitive Landscape:

The Spinal Muscular Atrophy (SMA) Treatment Market is characterized by intense competition, with several key players driving growth through innovation, market expansion, and strategic investments. The competitive landscape provides valuable insights into the industry’s leading companies, highlighting their strengths, financial performance, and market influence.

Leading Companies in the Global Spinal Muscular Atrophy (SMA) Treatment Market are:

Biogen

Novartis AG

Hoffmann-La Roche Ltd

Cytokinetics

PTC Therapeutics, Inc.

Ionis Pharmaceuticals Inc.

Astellas Pharma Inc.

NMD Pharma A/S

Genzyme Corporation

Genentech, Inc.

Pfizer Inc.

Scholar Rock Holding Corporation

Novo Nordisk A/S

Takeda Pharmaceutical Co. Ltd.

The Global Spinal Muscular Atrophy (SMA) Treatment Industry Recent Development:

October 2024: Biogen Inc. reported data concerning the efficacy of nusinersen under the higher dose regimen from Parts B and C of the DEVOTE combined Phase 2/3 trial for infantile-onset, as well as later-onset spinal muscular atrophy in pre-treated-and-untreated-patients.

March 2023, innovation in Zolgensma®, female name onasemnogene abeparvovec, was claimed by Novartis as a fitting one-time gene therapy essential for spinal muscular atrophy.

Questions Addressed in this Study

1.What factors are driving the Global Spinal Muscular Atrophy (SMA) Treatment Market growth?

2.How is the Global Spinal Muscular Atrophy (SMA) Treatment Market expected to grow over the next five years?

3.What are the key insights into the current trends in the Global Spinal Muscular Atrophy (SMA) Treatment Market?

4.What is the current size of the Global Spinal Muscular Atrophy (SMA) Treatment Market, and how is it projected to change in the future?

6.What is the future outlook for the Global Spinal Muscular Atrophy (SMA) Treatment Market in terms of technological advancements and market expansion?

For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/spinal-muscular-atrophy-sma-treatment-market.html

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

More Research Studies Report:

-Biocomposites Market size was valued at around USD 36.9 billion in 2024 and is projected to reach USD 89 billion by 2030 with a CAGR of around 16%.

-Green Solvents Market size was valued at around USD 1.34 billion in 2024 & is projected to reach USD 1.87 billion by 2030 with a CAGR of around 5.7%.

For Media Inquiries, Please Contact:

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India